DG
CELG

Davidson & Garrard’s Celgene Corp CELG Stock Holding History

Davidson & Garrard’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.8M Buy
12,333
+730
+6% +$99.4K 0.42% 71
2017
Q2 		$1.51M Buy
11,603
+535
+5% +$65.6K 0.36% 77
2017
Q1 		$1.38M Sell
11,068
-171
-2% -$20.5K 0.33% 82
2016
Q4 		$1.3M Sell
11,239
-475
-4% -$52.9K 0.32% 82
2016
Q3 		$1.22M Buy
11,714
+3,929
+50% +$425K 0.3% 86
2016
Q2 		$768K Buy
+7,785
New +$805K 0.19% 114

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Davidson & Garrard's CELG Position: Q3 2017 in Review

Davidson & Garrard increased its Celgene Corp (CELG) stake by 6.3% in Q3 2017, buying an estimated $99.4K and bringing the position to 12,333 shares worth $1.8M. The position accounts for 0.42% of the portfolio, ranked #71.

Davidson & Garrard first reported a position in CELG in Q2 2016 and has held it in 6 quarters since. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • Davidson & Garrard held 12,333 shares of Celgene Corp worth $1.8M as of Q3 2017.
  • Davidson & Garrard bought 730 Celgene Corp shares in Q3 2017, an estimated $99.4K.
  • Celgene Corp made up 0.42% of Davidson & Garrard's portfolio in Q3 2017, its #71 holding.
  • Davidson & Garrard first reported a position in Celgene Corp in Q2 2016 and has held it in 6 quarters since.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.